I am/have/had
I am looking for
Advanced Filters
Found 3 clinical trials
Featured trial
Clinical Study Protocol Abbvie M11-352
Clinical Study Protocol Abbvie M11-352
- 332 views
- 25 Mar, 2021
- 1 location
Atrasentan in Patients With IgA Nephropathy (ALIGN)
The ALIGN Study is a phase 3, double-blind, placebo-controlled study to compare the efficacy and safety of atrasentan to placebo in patients with IgA nephropathy (IgAN) at risk of progressive
renal function
nephropathy
- 47 views
- 04 Oct, 2022
- 119 locations
Atrasentan in Patients With Proteinuric Glomerular Diseases (AFFINITY)
The AFFINITY Study is a phase 2, open-label, basket study to evaluate the efficacy and safety of atrasentan in patients with proteinuric glomerular disease who are at risk of progressive loss of
ras inhibitor
corticosteroids
type 2 diabetes
renal function
atrasentan
- 31 views
- 04 Oct, 2022
- 36 locations